Bill Information for HB 2801

HB 2801 by Marti

Select Session:

Enter Bill #:

Antipsychotic drugs; vendor drug program; Oklahoma Health Care Authority; prior authorized; disorders; prior authorization; effective date.

History

Amendments

Bill Summaries

Versions

Votes

Authors/Co Authors

History For HB 2801
Action	Journal Page	Date	Chamber
First Reading	307	02/03/2025	H

Authored by Representative Marti	307	02/03/2025	H

Second Reading referred to Health and Human Services Oversight		02/04/2025	H

Referred to Public Health		02/04/2025	H

Floor Amendments (Senate)
None
Floor Amendments (House)
None
Committee Amendments (Senate)
None
Committee Amendments (House)
None
Sub Committee OR Policy Committee Recommendations (House)
None

Bill Summaries/Fiscal Impact for HB 2801 (House)
Introduced	2/5/2025

Bill Summaries/Fiscal Impact for HB 2801 (Senate)
None
OPLAA Actuarial Statements For HB 2801 (House)
None
OPLAA Actuarial Statements For HB 2801 (Senate)
None
Fiscal Impact Statements For HB 2801 (House)
None
Fiscal Impact Statements For HB 2801 (Senate)
None

Versions of HB 2801
Introduced	1/16/2025

Committee Reports for HB 2801
Conference Committee Reports for HB 2801

Votes on HB 2801
None

***To be added when the next official action is taken on the measure.***

Address: 2300 N Lincoln Blvd., State Capitol Building, Oklahoma City, OK 73105